Cargando…
A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19
Influenza virus and coronavirus, two kinds of pathogens that exist widely in nature, are common emerging pathogens that cause respiratory tract infections in humans. In December 2019, a novel coronavirus SARS-CoV-2 emerged, causing a severe respiratory infection named COVID-19 in humans, and raising...
Autores principales: | Luo, Junhao, Zhang, Zhuohan, Zhao, Song, Gao, Rongbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094131/ https://www.ncbi.nlm.nih.gov/pubmed/37047339 http://dx.doi.org/10.3390/ijms24076369 |
Ejemplares similares
-
Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice
por: Zhang, Zhuohan, et al.
Publicado: (2022) -
Development and Effects of Influenza Antiviral Drugs
por: Yin, Hang, et al.
Publicado: (2021) -
Pandemic influenza: overview of vaccines and antiviral drugs.
por: Cox, Manon M. J.
Publicado: (2005) -
Antiviral Drugs in Influenza
por: Świerczyńska, Magdalena, et al.
Publicado: (2022) -
Inflammasomes in antiviral immunity: clues for influenza vaccine development
por: Yamazaki, Tatsuya, et al.
Publicado: (2014)